Gain of 8q has been reported as a relatively common event in HNSCC, particularly at 8q24 [41], which houses the MYC oncogene, and 8q22, thought to be targeting LRP12[42]. The gene discussed is MYC; the disease is head and neck squamous cell carcinoma.